Finance

Beta
Ask
Lists
000153:SHE
Anhui Fengyuan Pharmaceutical Co., Ltd.
CN¥5.36
-2.01%
(-0.11) 1D
Jun 17, 3:04:12 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 000153...
Open
CN¥5.46
High
CN¥5.48
Low
CN¥5.34
Mkt. cap
2.54B
Avg. vol.
7.01M
Volume
5.50M
Dividend
1.87%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
25.32
52-wk high
CN¥8.08
52-wk low
CN¥5.32
EPS
CN¥0.21
Shares outstanding
464.69M
No. of employees
4K
Open
CN¥5.46
High
CN¥5.48
Low
CN¥5.34
Mkt. cap
2.54B
Avg. vol.
7.01M
Volume
5.50M
Dividend
1.87%
Quarterly dividend
CN¥0.02
Ex-dividend date
Jun 18, 2026
P/E ratio
25.32
52-wk high
CN¥8.08
52-wk low
CN¥5.32
EPS
CN¥0.21
Shares outstanding
464.69M
No. of employees
4K
News stories
From sources across the web
About Anhui Fengyuan Pharmaceutical Co., Ltd.
CEO-
Employees4.28K
FoundedAug 30, 1997
Headquarters-
SectorPharmaceutical industry
Websitebbcayy.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CNY
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
1.09B
1.10B
733.07M
835.92M
Cost of goods sold
895.64M
948.42M
580.93M
644.51M
Cost of revenue
895.64M
948.42M
580.93M
644.51M
Research and development expenses
14.76M
12.18M
4.77M
6.42M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
126.77M
109.42M
108.52M
129.73M
Operating expense
152.08M
132.21M
124.19M
140.58M
Total operating expenses
1.05B
1.08B
705.12M
785.09M
Operating income
38.67M
17.37M
27.95M
50.84M
Other non operating income
-294.76K
103.61K
-3.08M
-376.70K
EBT including unusual items
44.31M
25.52M
11.23M
44.44M
EBT excluding unusual items
31.89M
16.56M
16.34M
45.18M
Income tax expense
6.64M
2.30M
14.64M
8.00M
Effective tax rate
14.98%
9.03%
130.37%
18.01%
Other operating expenses
8.96M
8.52M
421.98K
1.82M
Net income
38.26M
24.01M
-868.40K
37.01M
Net profit margin
3.52%
2.19%
-0.12%
4.43%
Earnings per share
-
-
-
-
Interest and investment income
1.06M
9.22M
365.49K
2.01M
Interest expense
-7.82M
-9.85M
-9.19M
-7.29M
Net interest expenses
-6.76M
-635.10K
-8.83M
-5.28M
Depreciation and amortization charges
-
-
-
-
EBITDA
68.54M
42.47M
58.19M
81.08M
Gain or loss from assets sale
-
-
326.42K
-
AI content may include mistakes. Learn more
AI content may include mistakes. Learn more